PLUS THERAPEUTICS, Inc. - stock earnings
PSTV Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 12, 2024 BeforeMarket | - / - | 1.7 million | - / 1.7 million | 1.8 million |
PSTV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -3.3 million USD | 1.7 million USD |
| 2023Q4 | -3.8 million USD | 1.3 million USD |
| 2023Q3 | -3.2 million USD | 1.2 million USD |
| 2023Q2 | -1.5 million USD | 1.9 million USD |
| 2023Q1 | -4.8 million USD | 506000 USD |
| 2022Q4 | -5.7 million USD | 224000 USD |
| 2022Q3 | -5.3 million USD | 73000 USD |
| 2022Q2 | -5.4 million USD | ? USD |
| 2022Q1 | -4.3 million USD | ? USD |
| 2021Q4 | -4.2 million USD | ? USD |
| 2021Q3 | -3.7 million USD | 18 USD |
| 2021Q2 | -2.8 million USD | 1469 USD |
| 2021Q1 | -2.7 million USD | ? USD |
| 2020Q4 | -3.6 million USD | ? USD |
| 2020Q3 | -1.7 million USD | ? USD |
| 2020Q2 | -1.8 million USD | 185000 USD |
| 2020Q1 | -1.1 million USD | 118000 USD |
| 2019Q4 | 884000 USD | 1.2 million USD |
| 2019Q3 | 526000 USD | 4.8 million USD |
| 2019Q2 | -9.1 million USD | 302000 USD |
| 2019Q1 | -3.2 million USD | 1.4 million USD |
| 2018Q4 | -2.2 million USD | 2.1 million USD |
| 2018Q3 | -2.3 million USD | 1.3 million USD |
| 2018Q2 | -3.7 million USD | 1.6 million USD |
| 2018Q1 | -4.4 million USD | 1.6 million USD |
| 2017Q4 | -4.3 million USD | 1.5 million USD |
| 2017Q3 | -4.8 million USD | 1.8 million USD |
| 2017Q2 | -6.0 million USD | 1.5 million USD |
| 2017Q1 | -7.5 million USD | 1.6 million USD |
| 2016Q4 | -4.9 million USD | 3.0 million USD |
| 2016Q3 | -5.4 million USD | 2.6 million USD |
| 2016Q2 | -6.4 million USD | 2.8 million USD |
| 2016Q1 | -5.3 million USD | 2.9 million USD |
| 2015Q4 | -2.8 million USD | 3.4 million USD |
| 2015Q3 | 1.5 million USD | 2.5 million USD |
| 2015Q2 | 4.5 million USD | 3.5 million USD |
| 2015Q1 | -22.0 million USD | 2.3 million USD |
| 2014Q4 | -5.8 million USD | 3.8 million USD |
| 2014Q3 | -9.4 million USD | 1.1 million USD |
| 2014Q2 | -11.8 million USD | 1.3 million USD |
| 2014Q1 | -10.4 million USD | 1.4 million USD |
| 2013Q4 | -10.0 million USD | 3.5 million USD |
| 2013Q3 | -5.3 million USD | 2.7 million USD |
| 2013Q2 | -3.2 million USD | 2.3 million USD |
| 2013Q1 | -7.7 million USD | 3.8 million USD |
| 2012Q4 | -3.8 million USD | 7.3 million USD |
| 2012Q3 | -11.2 million USD | 1.3 million USD |
| 2012Q2 | -7.9 million USD | 4.4 million USD |
| 2012Q1 | -9.3 million USD | 1.5 million USD |
| 2011Q4 | -6.9 million USD | 825000 USD |
| 2011Q3 | -8.3 million USD | 2.1 million USD |
| 2011Q2 | -5.1 million USD | 2.4 million USD |
| 2011Q1 | -12.1 million USD | 2.6 million USD |
| 2010Q4 | -9.3 million USD | 2.6 million USD |
| 2010Q3 | -10.4 million USD | 1.5 million USD |
| 2010Q2 | -5.4 million USD | 2.1 million USD |
| 2010Q1 | -2.4 million USD | 4.4 million USD |
| 2009Q4 | -9.5 million USD | 2.9 million USD |
| 2009Q3 | -6.8 million USD | 1.4 million USD |
| 2009Q2 | -826000 USD | 8.5 million USD |
| 2009Q1 | -6.1 million USD | 1.9 million USD |
| 2008Q4 | -6.5 million USD | -172000 USD |
| 2008Q3 | -6.8 million USD | 2.3 million USD |
| 2008Q2 | -8.4 million USD | 1.4 million USD |
| 2008Q1 | -8.3 million USD | 153000 USD |
| 2007Q4 | -10.7 million USD | 24000 USD |
| 2007Q3 | -5.3 million USD | 3.4 million USD |
| 2007Q2 | -4.0 million USD | 512000 USD |
| 2007Q1 | -1.9 million USD | 6.8 million USD |
| 2006Q4 | -1.9 million USD | 6.8 million USD |
| 2006Q3 | -8.8 million USD | 133000 USD |
| 2006Q2 | -7.3 million USD | 453000 USD |
| 2006Q1 | -7.5 million USD | 502000 USD |
| 2005Q4 | -14.4 million USD | 722000 USD |
| 2005Q3 | -2.3 million USD | 1.6 million USD |
| 2005Q2 | -5.4 million USD | 1.5 million USD |
| 2005Q1 | -4.5 million USD | 1.8 million USD |
| 2004Q4 | -4.3 million USD | 1.2 million USD |
| 2004Q3 | 4.5 million USD | 1.8 million USD |
| 2004Q2 | -3.8 million USD | 1.5 million USD |
| 2004Q1 | 1.5 million USD | 2.4 million USD |
| 2003Q4 | -1.1 million USD | 4.8 million USD |
| 2003Q3 | -2.8 million USD | 4.5 million USD |
| 2003Q2 | -2.1 million USD | 2.9 million USD |
| 2003Q1 | -3.3 million USD | 1.9 million USD |
| 2002Q4 | -5.5 million USD | 2.0 million USD |
| 2002Q3 | -3.0 million USD | 3.3 million USD |
| 2002Q2 | -1.6 million USD | 2.7 million USD |
| 2002Q1 | -2.9 million USD | 1.1 million USD |
| 2001Q4 | -2.9 million USD | 1.5 million USD |
| 2001Q3 | -2.7 million USD | 1.4 million USD |
| 2001Q2 | -4.3 million USD | 768000 USD |
| 2001Q1 | -1.1 million USD | 2.0 million USD |
PSTV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.3 million USD | 4.9 million USD |
| 2022 | -20.8 million USD | 224000 USD |
| 2021 | -14.3 million USD | ? USD |
| 2020 | -9.3 million USD | 303000 USD |
| 2019 | -12.7 million USD | 7.0 million USD |
| 2018 | -12.6 million USD | 3.0 million USD |
| 2017 | -22.7 million USD | 6.4 million USD |
| 2016 | -22.0 million USD | 11.4 million USD |
| 2015 | -18.7 million USD | 11.7 million USD |
| 2014 | -37.4 million USD | 7.6 million USD |
| 2013 | -26.2 million USD | 12.2 million USD |
| 2012 | -32.3 million USD | 14.5 million USD |
| 2011 | -32.5 million USD | 10.0 million USD |
| 2010 | -27.5 million USD | 10.6 million USD |
| 2009 | -23.2 million USD | 8.9 million USD |
| 2008 | -30.0 million USD | 4.5 million USD |
| 2007 | -28.7 million USD | 6.0 million USD |
| 2006 | -25.4 million USD | 7.9 million USD |
| 2005 | -26.5 million USD | 5.6 million USD |
| 2004 | -2.1 million USD | 6.8 million USD |
| 2003 | -9.3 million USD | 14.1 million USD |
| 2002 | -13.0 million USD | 9.2 million USD |
| 2001 | -11.2 million USD | 5.6 million USD |
| 2000 | -8.6 million USD | 6.3 million USD |
| 1999 | -4.6 million USD | 1.5 million USD |
| 1998 | -2.1 million USD | ? USD |
PSTV
Price: $2.14
52 week price:
Earnings Per Share: -4.24 USD
P/E Ratio: -0.34
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 204800
Market Capitalization: 12.1 million